河野和、藤原志保、和田奈緒子、井崎幹子、幸宏道、奥野豊、猪山賢一、山崎浩、坂井晃*、満屋裕明、畑裕之：骨髄腫細胞におけるCD138発現の低下．第37回日本骨髄腫学会学術集会、京都市、2012.7.7.（日本骨髄腫学会誌 2(1)：12、2012.7） Yawara Kawano, Shiho Fujiwara, Naoko Wada, Mikiko Izaki, Hiromichi Yuki, Yutaka Okuno, Kenichi Iyama, Hiroshi Yamasaki, Akira Sakai*, Hiroaki Mitsuya, Hiroyuki Hata：CD138-low MM cells are of immature phenotype and low sensitivity to lenalidomide. The 10th Annual Meeting of Japanese Society of Medical Oncology, Kyoto, 2012.7.7 (International Journal of Myeloma 2(1):12, 2012.7)
Yoshiaki Kuroda, Takahiko Miyama, Hideo Hyodo, Akira Sakai*：Treatment of multiple myeloma and AL amyloidosis with bortezomib, cyclophosphamide, and dexamethasone. The 10th Annual Meeting of Japanese Society of Medical Oncology, Kyoto, 2012.7.7 (International Journal of Myeloma 2(1):26, 2012.7)
Yawara Kawano, Shiho Fujiwara, Naoko Wada, Mikihiko Izaki, Hiromichi Yuki, Yutaka Okuno, Kenichi Iyama, Hiroshi Yamasaki, Akira Sakai*, Hiroaki Mitsuya, Hiroyuki Hata :CD138-low MM cells are of immature phenotype and reduced lenalidomide(LEN) sensitivity. The 74th Annual Meeting of Japanese Society of Hematology, Kyoto, 2012.10.19 (The Japanese Journal of Clinical Hematology 53(9):446, 2012.9)
坂井晃 *：多発性骨髄腫の合併症とそのマネージメント―骨病変・腎障害・末梢神経障害― …. 第74回日本血液学会学術集会 、京都市、2012.10.20. (臨床血液 53(9):876, 2012.9) Akira Sakai*:Complications and their management in multiple myeloma.-bone disease, renal impairment, peripheral neuropathy-The 74th Annual Meeting of Japanese Society of Hematology, Kyoto, 2012.10.20 (The Japanese Journal of Clinical Hematology 53(9):876, 2012.9)
Shinsuke Iida, Kiyoshi Ando, Kensi Suzuki, Akira Sakai*, Michinori Ogura, Kensei Tobinai, Morio Matsumoto, Kosei Matsue, Yasuhito Terui, Kazuteru Ohashi, Takaaki Chou, Kazutaka Sunami, Atsushi Shinagawa, Nobuyuki Aotsuka, Hirohiko Shibayama, Takayuki Takahashi, Masami Ishii, Tomomitsu Hotta : : A phase I/II study of VMP as initial treatment for multiple myeloma in Japan. The 74th Annual Meeting of Japanese Society of Hematology, Kyoto, 2012.10.20(The Japanese Journal of Clinical Hematology 53(9):312, 2012.9)
Yoshiaki Kuroda, Hideo Hyodo, Koji Arihiro, Akira Sakai *: Clinical features of Castleman disease and treatment with tocilizumab . The 74th Annual Meeting of Japanese Society of Hematology, Kyoto, 2012.10.20(The Japanese Journal of Clinical Hematology 53(9):313, 2012.9)
Keichiro Mihara, Akira Sakai*, Yoshihiro Takihara, Akiko Kimura: Evaluation of B-lymphoma cells involved in bone marrow: usefulness of CD19-gating flow cytometry . The 74th Annual Meeting of Japanese Society of Hematology, Kyoto, 2012.10.20(The Japanese Journal of Clinical Hematology 53(9):356, 2012.9)
Takasu M., Higaki T., Tani C., Kiguchi M., Tatsugami F., Awai K., Kuroda Y.,Sakai A*. Patients with Multiple Myeloma: Finite Element Analysis Using Multidetector CT to Predict Pathological Fracture. Program in Brief, Radiological Society of North America 98th Scientific Assembly and Annual Meeting. p351, 2012.
Takasu M., Kaichi Y., Tanitame K., Date S., Akiyama Y., Awai K., Kuroda Y., Sakai A*: MR Evaluation of Multiple Myeloma at 3.0 T: How Does Protocol Selection Affect Lesion Conspicuity? Program in Brief, Radiological Society of North America 98th Scientific Assembly and Annual Meeting. p351, 2012.
